Catherine A Cotter

5PUBLICATIONS
19CO-AUTHORS
Nanotoxicology, health and safetyMedical virologyGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
Immunogenicity of poxvirus A16/G9 entry-fusion subcomplex and its restriction by A56/K2 protein informs vaccine design.

|Mar 27, 2024
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.

Catherine Jacob-Dolan, Darren Ty, David Hope

|Mar 27, 2023
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice.

Catherine A Cotter, Jeffrey L Americo, Patricia L Earl

|Jun 09, 2022
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.

Jeffrey L Americo, Catherine A Cotter, Patricia L Earl

|Mar 10, 2021
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.

Ruikang Liu, Jeffrey L Americo, Catherine A Cotter

Pageof 1

Frequent Collaborators

5 joint publications

Bernard Moss

1 joint publications

Noam Erez

1 joint publications

Catherine Jacob-Dolan

1 joint publications

Darren Ty